Meldonium

DB13723InvestigationalSmall molecule

Meldonium: Overview.

Mechanism: Pharmacologically active on Organic cation/carnitine transporter 2, Gamma-butyrobetaine dioxygenase, and ATP-dependent 6-phosphofructokinase, platelet type
Curator reviewed
Formula / weight: C₆H₁₄N₂O₂ · 146.19 g/mol (avg)
Code names: MET-88

Resolves to

Compound

UNII73H7UDN6ECCAS76144-81-5ChEMBLCHEMBL2104708ChEBI131843

Clinical / RWD

ATCC01EB22

Structure

InChIKeyPVBQYTCFVWZSJK-UHFFFAOYSA-NSMILESC[N+](C)(C)NCCC([O-])=O

Targets

O76082SLC22A5O75936BBOX1Q01813PFKP

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 5 drug categories

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Meldonium, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In